Yamazaki Rie, Koda Yuya, Abe Ryohei, Sakurai Masatoshi, Kikuchi Taku, Kato Jun, Ouchi Takeshi, Mikami Shuji, Mori Takehiko
Division of Hematology, Department of Medicine, Keio University School of Medicine.
Center of Transfusion Medicine and Cell Therapy, Keio University Hospital.
Rinsho Ketsueki. 2021;62(1):25-29. doi: 10.11406/rinketsu.62.25.
A 44-year-old woman was diagnosed with anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) with clinical stage IVA (nodal and bladder involvement). Complete response (CR) was achieved after the CHOP chemotherapy; however, 12 months after the last course of chemotherapy, ALCL relapsed in the form of skin lesions without nodal involvement. After achieving a second CR with chemotherapy, autologous stem cell transplantation was performed. Two months after transplantation, the disease again relapsed as multiple skin lesions. Electron beam irradiation was performed; however, other skin lesions appeared thereafter and spontaneously disappeared. At present, 3.4 years after the transplantation, the patient is free from disease. ALK-positive ALCL relapsing as skin lesions may behave differently from the nodal relapse. An accumulation of cases is required to elucidate ALCL characteristics relapsing as skin lesions.
一名44岁女性被诊断为间变性淋巴瘤激酶(ALK)阳性间变性大细胞淋巴瘤(ALCL),临床分期为IVA期(淋巴结和膀胱受累)。CHOP化疗后达到完全缓解(CR);然而,在最后一个化疗疗程后12个月,ALCL以无淋巴结受累的皮肤病变形式复发。化疗再次达到第二次CR后,进行了自体干细胞移植。移植后两个月,疾病再次以多发皮肤病变的形式复发。进行了电子束照射;然而,此后又出现了其他皮肤病变并自行消失。目前,移植后3.4年,患者无病生存。以皮肤病变形式复发的ALK阳性ALCL的行为可能与淋巴结复发不同。需要积累病例以阐明以皮肤病变形式复发的ALCL的特征。